Search for: "Reckitt Benckiser Inc." Results 41 - 53 of 53
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 May 2016, 3:15 am
Mini Melts, Inc. v Reckitt Benckiser LLC, Opposition No. 91173963 (April 27, 2016) [precedential].Likelihood of Confusion: Not surprisingly, the Board found the marks to be virtually identical, and therefore this first du Pont factor weighed heavily in opposer's favor. [read post]
12 Jul 2019, 9:00 am
 The first is that probably the four highest profile design cases in the UK in recent years (Procter & Gamble Co v Reckitt Benckiser (UK) Ltd [2007] EWCA Civ 936, Dyson v Vax [2011] EWCA Civ 1206, Samsung Electronics (UK) Ltd v Apple Inc [2012] EWCA Civ 1339, and PMS International Limited v Magmatic Limited [2016] UKSC 12 (i.e. [read post]
Reckitt Benckiser LLC, the Delaware District Court speculated that the doctrine may be more limited when applied to willful infringement and enhanced damages.[20]  The court noted that, if a defendant was willfully blind to a patent covering a product that it copied and then sold, it “could satisfy the knowledge requirement for willful infringement, because the defendant’s willful blindness demonstrates the same level of culpability as if the defendant copied the… [read post]
11 Jan 2022, 11:45 am by luiza
This settlement, with all 50 states and DC, is in addition to a $600 million settlement that Indivior reached with the federal government in 2020, placing third on last year’s list, and the $1.4 billion resolution with Indivior’s former parent, Reckitt Benckiser Group PLC (“RB Group”) which topped the 2019 list of healthcare recoveries. [read post]
8 Jul 2009, 7:04 am
– CAFC decision in Agilent Techs v Affymetrix concerning claims pertaining to ‘microarray hybridization’ (Gray on Claims) US: Counterclaims dismissed in Alzheimer’s Institute/ Mayo patent licensing dispute over transgenic mice (Patent Docs)   Products (Tavanic) Levofloxacin – UK: EWCA upholds decision that Daiichi’s Levofloxacin patent and SPC both invalid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd and Daiichi Sankyo Co Ltd… [read post]
11 Jan 2022, 11:45 am by luiza
This settlement, with all 50 states and DC, is in addition to a $600 million settlement that Indivior reached with the federal government in 2020, placing third on last year’s list, and the $1.4 billion resolution with Indivior’s former parent, Reckitt Benckiser Group PLC (“RB Group”) which topped the 2019 list of healthcare recoveries. [read post]
27 Jan 2020, 5:26 pm by Ben Vernia
 In another matter, Reckitt Benckiser Group plc paid a total of $1.4 billion to resolve criminal and civil liability related to the marketing of the opioid addiction treatment drug Suboxone, which is a formulation of the opioid buprenorphine. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most Americans… [read post]